Viewing nowCombinationTelmisartan and Amlodipine Tablets 80/5 mg
Telmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.

MFDS item code 201605777 · Approved 2016.09.30 · Insurance code 693902380
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not sufficiently controlled with monotherapy of Amlodipine or Telmisartan. It effectively lowers blood pressure, aiding in hypertension management. Essential hypertension refers to a persistent high blood pressure state, and appropriate treatment is crucial. This medication stabilizes blood pressure by dilating blood vessels or improving blood pressure control mechanisms, thus reducing the patient's cardiovascular risk and contributing to maintaining healthy blood pressure. It assists in the prevention of complications by improving hypertension management.
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take the tablet at the same time each day (e.g., in the morning). It is recommended to adjust the dose using the individual components (amlodipine or telmisartan) before administering this medicine. However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, it is recommended to start treatment at a low dose and gradually increase the dose. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication should not be used during pregnancy, especially in the second and third trimesters, as it can pose serious risks to the fetus. If pregnancy is confirmed, the use of this medication should be discontinued immediately, and a doctor should be consulted. Additionally, patients with known allergies to any of the components of this medication, or those with certain heart conditions, or severely impaired liver or kidney function, should not take it. It is also unsafe for breastfeeding women. This medication is not suitable for patients with excessively low blood pressure or in a state of shock. Special caution is required when using this medication in patients with certain heart valve diseases or liver diseases. Patients with gastrointestinal diseases or vascular kidney issues should strictly follow their doctor's instructions when taking this medication. Elderly patients may be more sensitive to this medication, so caution is advised during use. Dizziness and peripheral edema may occur while taking this medication, so any unusual symptoms should be reported to a doctor. There may be interactions with other medications, so all prescribed medications should be disclosed to the doctor. Caution is needed as this medication may lead to kidney function impairment or excessive blood pressure reduction when used in combination with certain drugs. Caution is also warranted when driving or operating machinery due to potential drowsiness or dizziness. In case of overdose, symptoms such as hypotension, dizziness, or heart problems may occur, necessitating immediate medical attention. The safety and efficacy of this medication have not been sufficiently established for children and adolescents.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a container that blocks light. It is advisable to store the medication at room temperature between 1 to 30 degrees Celsius. Proper storage maintains the effectiveness and stability of the medication.
A white and light gray, double convex, oval-shaped tablet.
30 tablets (10 tablets/PTP X 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.